Two Sigma Investments’s Cellyan Biotechnology HKPD Stock Holding History

Two Sigma Investments’s Portfolio HKPD Stock Details HKPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.16K	Sell	10,832 -5,919	-35%	-$4.31K	﹤0.01%	4540
2025 Q4	$13.8K	Buy	+16,751	New	+$18K	﹤0.01%	4018

Other funds holding HKPD

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments's HKPD Position: Q1 2026 in Review

Two Sigma Investments reduced its Cellyan Biotechnology (HKPD) stake by 35% in Q1 2026, selling an estimated $4.31K and leaving 10,832 shares worth $6.16K. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

Two Sigma Investments first reported a position in HKPD in Q4 2025 and has held it in 2 quarters since. The position peaked at $13.8K in Q4 2025. 4 funds tracked by Wall St. Rank hold HKPD as of Q1 2026.

Two Sigma Investments held 10,832 shares of Cellyan Biotechnology worth $6.16K as of Q1 2026.
Two Sigma Investments sold 5,919 Cellyan Biotechnology shares in Q1 2026, an estimated $4.31K.
Cellyan Biotechnology made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4540 holding.
Two Sigma Investments first reported a position in Cellyan Biotechnology in Q4 2025 and has held it in 2 quarters since.
Two Sigma Investments's Cellyan Biotechnology position peaked at $13.8K in Q4 2025.
4 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.